Skip to main navigation
Skip to search
Skip to main content
University of Haifa Home
Update your profile
Link opens in a new tab
Search content at University of Haifa
Home
Researchers
Research units
Research output
Antimicrobial susceptibility of Clostridium difficile isolates in Israel
Linda Tkhawkho
, Orna Nitzan
, Nina Pastukh
, Diana Brodsky
, Karen Jackson
,
Avi Peretz
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antimicrobial susceptibility of Clostridium difficile isolates in Israel'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Israel
100%
Reduced Susceptibility
100%
Clostridioides Difficile
100%
Antimicrobial Susceptibility
100%
Vancomycin
100%
Metronidazole
85%
Moxifloxacin
57%
NAP1
57%
Northern Israel
42%
Antibiotics
42%
Non-susceptible
42%
Susceptibility Rate
42%
Tigecycline
42%
Ribotyping
28%
C. Difficile
28%
Statistical Test
14%
Stool Samples
14%
Sensitivity Test
14%
Antimicrobial
14%
Antibiotic Resistance
14%
Resistance Rate
14%
Differences in Distributions
14%
Tigecycline Resistance
14%
C. Difficile Infection
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
100%
Peptoclostridium difficile
100%
Vancomycin
100%
Metronidazole
85%
Antibiotics
57%
Tigecycline
57%
Moxifloxacin
57%
Clostridium Difficile Infection
14%
Immunology and Microbiology
Antibiotic Sensitivity
100%
Peptoclostridium difficile
100%
Susceptibility
100%
Infectious Disease
10%
Minimum Inhibitory Concentration
10%
Infection
10%